Auto saved by Logseq

master
Borja Robert 11 months ago
parent 031de84d91
commit 762f4f8661

@ -53,7 +53,7 @@
- ## Objetivos y logros de los proyectos STOP previos (en background)
- Qualification at EMA for art. 58
- Safety of IVM up to 600μg/kg alone and in coformulation with albendazole
- Demonstrated efficacy agrainst T. trichiura in a pivotal trial in Sub-Saharan Africa
- Demonstrated efficacy against T. trichiura in a pivotal trial in Sub-Saharan Africa
- No stopping rules were reached
- Safety was adequate
- Palatability results confirm adecuacy of size, taste and smell
@ -85,4 +85,4 @@
- ## HOME
- ### Background
- Especificar que la novel formulation es una fixed-dose coformulation de [[Ivermectina]] y [[Albendazol]].
- Especificar que esta fixed-dose coformulation de ivm/alb es la lower
- Especificar que esta fixed-dose coformulation de ivm/alb has the lowest level of investment risk of all candidates for Combi
Loading…
Cancel
Save